Multi Medika Internasional Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Multi Medika Internasional Tbk. trades at Rp760 (market cap 3.72T, 43.61M 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,930 (market cap 165.24T, 271.53M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 44.4× Multi Medika Internasional Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (271.53M versus 43.61M). Which is the better fit depends on your goals.
| MMIX | TPIA | |
|---|---|---|
Market Cap | 3.72T | 165.24T |
Volume | 43.61M | 271.53M |
Lot | 436.07K | 2.72M |
Turnover | 34.14B | 522.13B |
Average Price | 783.01 | 1,922.9 |
Value | 34.14B | 522.13B |
Indicative Equilibrium Price | 760 | 1,930 |
Indicative Equilibrium Volume | 3.21K | 69.58K |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →